Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia B

NCT01027364 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Hemophilia B

Interventions

DRUG: Factor IX (rFIXFc)
DRUG: rFIX

Sponsor

Bioverativ Therapeutics Inc.

Collaborators

[object Object]